Skip to main content

BURDENKO-GBM-PROGRESSION

Burdenko-GBM-Progression | Burdenko's Glioblastoma Progression Dataset

DOI: 10.7937/E1QP-D183 | Data Citation Required | Image Collection

Location Species Subjects Data Types Cancer Types Size Supporting Data Status Updated
Brain Human 180 CT, MR, RTSTRUCT, RTDOSE, RTPLAN Glioblastoma 131.23GB Clinical, Genomics, Software/Source Code Limited, Complete 2023/04/10

Summary

The Burdenko Glioblastoma Progression Dataset (BGPD) is a systematic data collection from 180 patients with primary glioblastoma treated at the Burdenko National Medical Research Center of Neurosurgery between 2014 and 2020. 

For each patient, the dataset includes imaging studies conducted for radiotherapy planning and follow-up studies. The radiotherapy studies consist of 4 MRI sequences (T1, T1C, T2, FLAIR), a topometric CT scan, and associated radiotherapy planning files (RTSTRUCT, RTPLAN, and RTDOSE). Follow-up studies (from 1 to 8-time per patient) include 2-4 MRI sequences (with a minimal set of T1C and FLAIR) per patient. Additional genetic information (IDH1/2, MGMT mutations); and a treatment response status (tumour progression, tumour pseudoprogression, treatment response) are available for a subset of patients. 

The MRI studies were obtained from different sites, with scanners from 4 vendors and varying scanning protocols. CT studies were obtained using a unified scanning protocol.

Planning and follow-up studies

Each RTSTRUCT contains information on Gross Tumour Volume (GTV), Clinical Target Volume (CTV), and Planning Target Volume (PTV). In addition, each RTSTRUCT includes annotations of 10 anatomical structures: Eyes (Left, Right), Lenses (Left, Right), Optic Nerves (Left, Right), Brain, Brain stem, Chiasm, and external contour (Head).  

For a subset of patients RTSTRUCTs include annotation of Gross Tumour Volume assessed on follow-up (longitudinal) studies.

For each patient, we supplement imaging information with clinical data: IDH1/2 gene mutation is available for 110 patients (97 negative, 13 positive), MGMT promoter methylation status is available for 92 patients (55 negative, 37 positive), death date is available for 80 patients (anonymized with preserved time shift), surgery date (anonymized with preserved time shift) and treatment response status (treatment response, tumour progression, tumour pseudoprogression) are available for all control studies.

Additional information

All MRIs are provided in the original acquisition space, while RTSTRUCTs, RTPLANs, and RTDOSEs are aligned with topometric CT scans. MRI to CT registration files are not provided as a part of the collection, however, here is a github link supporting a containerized solution (written in Python, based on ANTs library) that runs all necessary images and masks alignment. 

A subset of MRI images are para-transversal (direction cosine vectors as stored in Image Orientation Patient DICOM attribute form an orthonormal basis, but not a canonical one).

Data Access

Some data in this collection contains images that could potentially be used to reconstruct a human face. To safeguard the privacy of participants, users must sign and submit a TCIA Restricted License Agreement to help@cancerimagingarchive.net before accessing the data.

Version 1: Updated 2023/04/10

Title Data Type Format Access Points Subjects Studies Series Images License
Images and Radiation Therapy Structures/Doses/Plans MR, RTPLAN, RTDOSE, RTSTRUCT, CT DICOM
Download requires NBIA Data Retriever
180 645 4,956 344,003 TCIA Restricted
Clinical and Genomic data CSV CC BY 4.0

Additional Resources for this Dataset

The following external resources have been made available by the data submitters.  These are not hosted or supported by TCIA, but may be useful to researchers utilizing this collection.

Citations & Data Usage Policy

Data Citation Required: Users must abide by the TCIA Data Usage Policy and Restrictions. Attribution must include the following citation, including the Digital Object Identifier:

Data Citation

Zolotova, S. V., Golanov, A. V., Pronin, I. N., Dalechina, A. V., Nikolaeva, A. A., Belyashova, A. S., Usachev, D. Y., Kondrateva, E. A., Druzhinina, P. V., Shirokikh, B. N., Saparov, T. N., Belyaev, M. G., & Kurmukov, A. I. (2023). Burdenko’s Glioblastoma Progression Dataset (Burdenko-GBM-Progression) (Version 1) [Data set]. The Cancer Imaging Archive. https://doi.org/10.7937/E1QP-D183

Acknowledgements

We would like to acknowledge the individuals and institutions that have provided data for this collection:

  • Department of Radiosurgery and Radiotherapy of the Burdenko National Medical Research Center of Neurosurgery staff who were involved in the preparation of this dataset.
  • Special thanks to Stanislav Krasnyanskiy, MSc, and Gennady Gorlachev, Ph.D. for the technical support of the data export.

Other Publications Using this Data

TCIA maintains a list of publications which leverage TCIA data. If you have a manuscript you’d like to add please contact TCIA’s Helpdesk.

TCIA Citation

Clark, K., Vendt, B., Smith, K., Freymann, J., Kirby, J., Koppel, P., Moore, S., Phillips, S., Maffitt, D., Pringle, M., Tarbox, L., & Prior, F. (2013). The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository. In Journal of Digital Imaging (Vol. 26, Issue 6, pp. 1045–1057). Springer Science and Business Media LLC. https://doi.org/10.1007/s10278-013-9622-7